Metraipolis › archive › dc_07bea6d8a18a

Mortalin Represents a Promising Therapeutic Target for Oral Cancers: Clinical Relevance and Experimental Evidence for the Activation of Akt/mTOR Signaling — Europe PMC PMID:40940957

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40940957
DOI
10.3390/cancers17172860
License (as archived)
solo-consultazione
Archived
2026-11-10T06:30:15.538Z
SHA-256 of the archived text
9abb15c723a87c200845117061d048eefec3d9f521be68a79dce0a3ed046ac30
Stable URL of this page
https://metraipolis.com/documento/dc_07bea6d8a18a

How to cite

Mortalin Represents a Promising Therapeutic Target for Oral Cancers: Clinical Relevance and Experimental Evidence for the Activation of Akt/mTOR Signaling — Europe PMC PMID:40940957 — Europe PMC (en), https://europepmc.org/article/MED/40940957 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_07bea6d8a18a (Metraipolis archive dc_07bea6d8a18a, sha256 9abb15c723a87c200845117061d048eefec3d9f521be68a79dce0a3ed046ac30)
BibTeX
@misc{dc07bea6d8a18a,
  title = {Mortalin Represents a Promising Therapeutic Target for Oral Cancers: Clinical Relevance and Experimental Evidence for the Activation of Akt/mTOR Signaling — Europe PMC PMID:40940957},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40940957},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_07bea6d8a18a; sha256 9abb15c723a87c200845117061d048eefec3d9f521be68a79dce0a3ed046ac30},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40940957. Agents can read the archived copy with the MCP tool read_document.